Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 7 Issue 5

Measuring Mental Health with the SRQ-20 in Patients Living with HIV Followed at the Point-G University Hospital

Kamate E1*, Diakite A2, Diallo K3, Cisse T1, BA BS1, Ouologuem D1, Magassouba O1, Sogoba D1, Samake K1, Coulibay S4, Minta DK1

1Psychologist Infectious Diseases Department of Point G University Hospital, Bamako, Mali
2Radiotherapy Department, Hospital of Mali, Mali
3Health Sciences Training and Research Unit, Assane Seck University of Ziguinchor, Senegal
4Department of Psychiatry, CHU Point-G Bamako, Mali

*Corresponding Author: Kamate E, Psychologist Infectious Diseases Department of Point G University Hospital, Bamako, Mali.

Received: March 21, 2023; Published: April 06, 2023

Abstract

Introduction/Objectives: Despite the indisputable effectiveness of antiretroviral (ARV) treatment today, people living with HIV are still at increased risk of developing mental health disorders in resource-limited countries. Our work aimed to reduce the prevalence of mental health among patients living with HIV followed at the CHU du Point-G.

Methods: This was a descriptive cross-sectional study through prospective recruitment from August to December 2022 in HIV patients. The patients who accepted, benefited from an individual interview through a questionnaire containing the SRQ-20 French version.

Results: A total of 122 patients were enrolled, of which 55.74% were women. The mean age was 42.60 ± 11.55 years with extremes at 22 and 73 years. The mean duration on ARV treatment was 9.11 ± 5.35 years. The predominant occupations were housewives (30.1%), shopkeepers (22.8%) and teachers (8.9%). The prevalence of positive results for SRQ-20 was estimated to be 61.5% (95% CI 52.72-70.23; 75 cases) with apredominance of women (57.33%).

Conclusion: The results of our study show that there is an urgent need to address the issue of mental health in the context of HIV/AIDS in Mali today.

Keywords: SRQ-20; HIV; PHAs; Point G

References

  1. El Fane M., et al. “The mental health of patients living with HIV in the infectious diseases department of the CHU Casablanca, Morocco”. Annales Médico-psychologiques (Paris) (2018).
  2. Préau M., et al. “Anheedonia and depression in the context of HIV infection with multi-drug antiretroviral therapy (ANRS-EN12-VESPA)”. Encephale 34 (2008): 385-393.
  3. Kel CL., et al. “Psychiatric disorders and HIV infection”. In: Psychiatry, HIV and Hepatitis C (2009): 53-61.
  4. Minta DK., et al. “Psychiatric manifestations among people living with HIV in the internal medicine and infectious diseases departments at the University Hospital of Point Bamako, Mali”. Rev Cames Sante 1 (2013): 84-89.
  5. UNAIDS/PCB. “Thematic segment: Mental health and HIV/AIDS: promoting human rights, an integrated and people-centred approach to improving antiretroviral therapy, well-being and quality of life”. Geneva: UNAIDS (43)/18.32 (2018): 41.
  6. Ciesla JA and Roberts JE. “Meta-analysis of the relationship between HIV infection and risk for depressive disorders”. American Journal of Psychiatry5 (2001): 725-730.
  7. Patel P., et al. “Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis”. Aids 32 (2018): S5-s20.
  8. Sudfeld CR., et al. “Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV”. Aids 2 (2017): 263-271.
  9. Todd JV., et al. “Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women”. American Journal of Epidemiology (2017): 1-10.
  10. “Mental health: strengthening our action”. Geneva: WHO (2018).
  11. Bernède M. “Quality of life with HIV: an improvement in trompe-l'oeil?” Transversal HIV and AIDS Today (2019).
  12. Wagner GJ., et al. “Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda”. Psychosomatic Medicine9 (2012): 883-890.
  13. Chibanda D., et al. “Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countries”. Journal of Acquired Immune Deficiency Syndromes 67 (2014): S54-67.
  14. Kinyanda E., et al. “Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda”. BMC Psychiatry 11 (2011): 205.
  15. Beusenberg M and Orley J. “A user’s guide to the self reporting questionnaire (SRQ)”. Geneva: Division of Mental Health, World Health Organization (1994): 90.
  16. Van der Westhuizen C., et al. “Validation of the Self Reporting Questionnaire 20-Item (SRQ-20) for use in a low-and middle-income country emergency centre setting”. International Journal of Mental Health and Addiction1 (2015): 37-48.
  17. Sartorius N and Janca A. “Psychiatric assessment instruments developed by the World Health Organization”. Social Psychiatry and Psychiatric Epidemiology 31 (1996): 55-69.
  18. Chipimo PJ and Fylkesnes K. “Comparative validity of instruments for mental distress in Zambia”. Clinical Practice and Epidemiology in Mental Health 6 (2010): 4-15.
  19. Kawiya HH., et al. “Missed opportunities to address common mental disorders and risky alcohol use among people living with HIV in Zomba, Malawi: A cross sectional clinic survey”. PLoS ONE2 (2023): e0278160.
  20. E Nakimuli-Mpungu., et al. “Cross-cultural adaptation and validation of the self-reporting questionnaire among HIV+ individuals in a rural ART program in southern Uganda”. HIV AIDS-Research and Palliative Care 4 (2012): 51-60.
  21. Nogueira LFR., et al. “Common Mental Disorders are associated with higher viral load in People Living with HIV”. Rio de Janeiro; Saude Debate 43.121 (2019): 464-476
  22. , et al. “One-Third of Perinatal Women Living with HIV Had Perinatal Depression in Gondar Town Health Facilities, Northwest Ethiopia”. HIV/AIDS - Research and Palliative Care (2021): 887-895.
  23. Sikkema KJ., et al. “Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countries”. Global Mental Health 19 (2015): 1-23.
  24. Kaggwa MM., et al. “Prevalence of depression in Uganda: A systematic review and meta-analysis”. PLoS ONE 10 (2022): e0276552.
  25. Fischer M., et al. “Measuring and understanding depression in women in Kisoro, Uganda”. Culture, Medicine and Psychiatry 43 (2019): 160-180.
  26. Haneya E., et al. “One size does not fit all: Psychometric properties of the Shona Symptom Questionnaire (SSQ) and symptomology among adolescents and young adults in Zimbabwe”. Journal of Affective Disorders 167 (2014): 358-367.

Citation

Citation: Kamate E., et al. “Measuring Mental Health with the SRQ-20 in Patients Living with HIV Followed at the Point-G University Hospital”.Acta Scientific Medical Sciences 7.5 (2023): 49-54.

Copyright

Copyright: © 2023 Kamate E., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US